Patents by Inventor William Olson

William Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11732030
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: August 22, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Robert Babb, Alina Baum, Gang Chen, Cindy Gerson, Johanna Hansen, Tammy Huang, Christos Kyratsous, Wen-Yi Lee, Marine Malbec, Andrew Murphy, William Olson, Neil Stahl, George D. Yancopoulos
  • Patent number: 11678903
    Abstract: An apparatus comprises a body assembly and a shaft extending distally therefrom. The shaft defines a longitudinal axis. The apparatus further comprises an acoustic waveguide and an articulation section coupled with the shaft. A portion of the articulation section encompasses a flexible portion of the waveguide. The articulation section further comprises first member and a second member that is longitudinally translatable relative to the first member. The apparatus further comprises an end effector including an ultrasonic blade in acoustic communication with the waveguide. A distal portion the ultrasonic blade is disposed in a first direction away from the longitudinal axis at a bend angle. The end effector also includes a clamp arm that is coupled with the first member and the second member, and an articulation drive assembly operable to drive articulation of the articulation section to thereby deflect the end effector from the longitudinal axis in the first direction.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: June 20, 2023
    Assignee: Cilag GmbH International
    Inventors: Foster B. Stulen, William A. Olson, William B. Weisenburgh, II
  • Publication number: 20230174631
    Abstract: The present invention provides monoclonal antibodies that bind to the complement factor 5 (C5) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to C5 protein. In some embodiments, the antibodies of the invention are useful for inhibiting or neutralizing C5 activity, thus providing a means of treating or preventing a C5-related disease or disorder in humans. In some embodiments, the invention provides for an anti-C5 antibody that has improved pharmacokinetic and pharmacodynamic properties, e.g., a half-life of more than 10 days.
    Type: Application
    Filed: September 19, 2022
    Publication date: June 8, 2023
    Inventors: Ying Hu, Adrianna Latuszek, Carmelo Romano, William Olson
  • Publication number: 20230159639
    Abstract: Anti-CD8 antibodies, radiolabeled anti-CD8 antibodies, fluorescently labeled anti-CD8 antibodies and their use in imaging are provided herein. Included are methods of detecting the presence of CD8 proteins in a subject or sample.
    Type: Application
    Filed: October 26, 2022
    Publication date: May 25, 2023
    Inventors: Jason T. Giurleo, Dangshe Ma, William Olson, Gavin Thurston, Richard Tavare
  • Publication number: 20230128575
    Abstract: A surgical device, is disclosed herein. The surgical device can include an end effector including a clamp jaw, a trigger configured to open and close the clamp jaw, a sensor configured to detect a relative position of the trigger, and a control circuit communicably coupled to the sensor and a generator, wherein the control circuit is configured to cause the generator to administer energy associated with a surgical operation to be performed on the tissue, receive a signal from the sensor, determine that the clamp jaws are not positioned to administer the energy associated with the surgical operation, and cause the generator to administer energy configured to release the tissue from an ultrasonic blade, wherein the energy configured to release the tissue from the clamp jaw is different than the energy associated with a surgical operation to be performed on the tissue.
    Type: Application
    Filed: October 11, 2022
    Publication date: April 27, 2023
    Inventors: Jacob S. Gee, Michael A. Keenan, William A. Olson, Tyler N. Brehm, Cameron D. McLain, Kevin Price
  • Publication number: 20230112022
    Abstract: An apparatus comprises a body assembly, a shaft, an acoustic waveguide, an articulation section, an end effector, and an articulation drive assembly. The shaft extends distally from the body assembly and defines a longitudinal axis. The acoustic waveguide comprises a flexible portion. The articulation section is coupled with the shaft. A portion of the articulation section encompasses the flexible portion of the waveguide. The articulation section comprises a plurality of body portions aligned along the longitudinal axis and a flexible locking member. The flexible locking member is operable to secure the body portions in relation to each other and in relation to the shaft. The end effector comprises an ultrasonic blade in acoustic communication with the waveguide. The articulation drive assembly is operable to drive articulation of the articulation section to thereby deflect the end effector from the longitudinal axis.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 13, 2023
    Inventors: Barry C. Worrell, Benjamin J. Danziger, Benjamin D. Dickerson, Brian D. Black, Cara L. Shapiro, Charles J. Scheib, Craig N. Faller, Daniel J. Mumaw, David J. Cagle, David T. Martin, David A. Monroe, Disha V. Estera, Foster B. Stulen, Frederick L. Estera, Geoffrey S. Strobl, Gregory W. Johnson, Jacob S. Gee, Jason R. Sullivan, Jeffrey D. Messerly, Jeffrey S. Swayze, John A. Hibner, John B. Schulte, Joseph E. Hollo, Kristen G. Denzinger, Kristen L. D'Uva, Matthew C. Miller, Michael R. Lamping, Richard W. Timm, Rudolph H. Nobis, Ryan M. Asher, Stephen M. Leuck, Tylor C. Muhlenkamp, William B. Weisenburgh, II, William A. Olson
  • Publication number: 20230085435
    Abstract: An untucking resistant garment resists becoming untucked while being worn. The garment includes a garment body and an inner band of tacky material coupled to an inside surface of the garment body positioned proximate to a bottom opening of the garment body. An outer band of the tacky material is coupled to an outside surface of the garment body positioned proximate to the bottom opening.
    Type: Application
    Filed: September 16, 2021
    Publication date: March 16, 2023
    Inventors: William Olson, Travis Buysse
  • Publication number: 20230079407
    Abstract: Provided herein are antibodies and antigen-binding fragments that bind MSR1 and methods of use thereof. According to certain embodiments, the antibodies bind human MSR1 with high affinity. In certain embodiments, the antibodies bind MSR1 without blocking, or blocking less than 90%, of modified LDL binding to MSR1. In some embodiments, the antibodies bind cell surface expressed-MSR1 and are internalized. The antibodies of the invention may be fully human antibodies. The invention includes anti-MSR1 antibodies, or antigen-binding fragments thereof, conjugated to drugs or therapeutic compounds.
    Type: Application
    Filed: April 22, 2022
    Publication date: March 16, 2023
    Inventors: Jesper GROMADA, Viktoria GUSAROVA, Amy HAN, Sokol HAXHINASTO, Christos KYRATSOUS, Andrew J. MURPHY, Thomas NITTOLI, William OLSON, Matthew SLEEMAN, Anna ZUMSTEG
  • Patent number: 11602364
    Abstract: A surgical instrument includes an ultrasonic waveguide extending through a body assembly. An ultrasonic blade connects to the ultrasonic waveguide. A clamp arm assembly of the surgical instrument is able to move from an opened position for receiving a tissue toward a closed position for clamping the tissue. The clamp arm assembly includes a clamp body and a clamp pad facing the ultrasonic blade. A clamp arm actuator of the surgical instrument is able to move from a first position toward a second position to direct the clamp arm assembly from the opened position toward the closed position. A modular coupling of the surgical instrument connects to the clamp pad such that at least the clamp pad can be disconnected relative to the ultrasonic blade for replacement thereof.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: March 14, 2023
    Assignee: Cilag GmbH International
    Inventors: Ryan M. Asher, Gregory D. Bishop, Brian D. Black, Chad P. Boudreaux, David J. Cagle, William E. Clem, Joseph Dennis, Kristen G. Denzinger, Benjamin D. Dickerson, Kevin M. Fiebig, Ellen Burkart, Christina M. Hough, John V. Hunt, Cody R. Jackson, Cory G. Kimball, Jeffrey D. Messerly, Gabriel I. Myers, Ion V. Nicolaescu, William A. Olson, Candice Otrembiak, John K. Swain, Gregory A. Trees, John A. Weed, III, William B. Weisenburgh, II, Eitan T. Wiener, Barry C. Worrell, David C. Yates, Monica L. Zeckel
  • Patent number: 11603206
    Abstract: The disclosure is directed to an independent manual control system of an all-electric cabin pressure control system (CPCS). The manual control system may include a momentary electrical switch to manually set the position of an outflow valve (OFV) along with a closed loop control to hold the cabin pressure at the pressure setpoint. The closed loop control of the manual control system is independent from the automatic pressure control functions of the all-electric CPCS.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: March 14, 2023
    Assignee: Honeywell International Inc.
    Inventors: Darrell W. Horner, David Buck, Robert William Olson, Gerard McCoy
  • Patent number: 11583306
    Abstract: The present disclosure is directed to end effectors. An end effector includes an outer shaft extending along a longitudinal axis and an inner shaft partially located within the outer shaft. The end effector may include an ultrasonic blade. The inner shaft may include biased and unbiased portions. The inner shaft and outer shaft may be translatable relative to one another. At one translatable position, the biased portion of the inner shaft may be located within the outer shaft and the unbiased portion may be substantially straight along the longitudinal axis. At another translatable position, the biased portion of the inner shaft may be located outside of and distally positioned from the outer shaft such that the biased portion of the inner shaft is bent away from the longitudinal axis.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: February 21, 2023
    Assignee: Cilag GmbH International
    Inventors: William A. Olson, Jeffrey D. Messerly, Daniel W. Price, Kevin L. Houser, Craig N. Faller, William D. Dannaher, Sora Rhee, Tylor C. Muhlenkamp
  • Patent number: 11571482
    Abstract: The present invention provides antibodies that bind to Staphylococcus aureus Hemolysin A toxin, and methods of use. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to Hemolysin A. The antibodies of the invention are useful for inhibiting or neutralizing Hemolysin A activity, thus providing a means of preventing or treating a Hemolysin A-related disease or disorder such as S. aureus infection. In some embodiments, the antibodies of the present invention are used in treating at least one symptom or complication of a S. aureus infection.
    Type: Grant
    Filed: January 27, 2021
    Date of Patent: February 7, 2023
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Alida Coppi, Peter Mason, William Olson
  • Publication number: 20230035898
    Abstract: Provided herein are compounds, compositions, conjugates and methods for the treatment of diseases, and/or conditions such as, but not limited to, proliferative diseases. In certain embodiments, compounds, compositions, and conjugates are provided, which include cyclodextrin-based linker-payloads and protein conjugates thereof, and/or in combination with other agents. By administering these compounds, compositions, and conjugates as described herein to specific target cells, side-effects due to non-specific binding phenomena, for example, to non-target cells are reduced.
    Type: Application
    Filed: June 10, 2022
    Publication date: February 2, 2023
    Inventors: Amy Han, William Olson
  • Patent number: 11559576
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: January 24, 2023
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • Publication number: 20220411487
    Abstract: Provided herein are monoclonal antibodies that bind to the transmembrane serine protease 6 (TMPRSS6) protein, and methods of use thereof. In various embodiments of the disclosure, the antibodies are fully human antibodies that bind to TMPRSS6. In some embodiments, the antibodies disclosed herein are useful in a method for treating or preventing a disease, disorder or condition associated with TMPRSS6 in humans.
    Type: Application
    Filed: May 10, 2022
    Publication date: December 29, 2022
    Inventors: Harvey CHIN, Sarah J. HATSELL, Heinrich Emil LOB, Andrew J. MURPHY, William OLSON, Kei SAOTOME, Bojie ZHANG
  • Patent number: 11530255
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to Ebola virus glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing Ebola virus activity, thus providing a means of treating or preventing Ebola virus infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the Ebola virus for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: December 20, 2022
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Christos Kyratsous, William Olson, Peter Mason, Neil Stahl
  • Patent number: 11529164
    Abstract: A surgical apparatus comprises a body, an ultrasonic transducer, a shaft, and an end effector. The ultrasonic transducer is operable to convert electrical power into ultrasonic vibrations. The shaft couples the end effector and the body together. The end effector comprises an ultrasonic blade in acoustic communication with the ultrasonic transducer. The ultrasonic blade includes a recess region having a plurality of recesses. The recess region is tapered such that the cross-sectional area of the recess region decreases along the length of the recess region. The ultrasonic blade is also curved such that a central longitudinal axis of the ultrasonic blade extends along a curved path. A reference circuit is used to account for voltage drops of unknown values during operation of the surgical apparatus.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: December 20, 2022
    Assignee: Cilag GmbH International
    Inventors: Foster B. Stulen, John B. Schulte, Jeffrey L. Aldridge, Jeffery T. Kirk, Randal T. Byrum, Douglas J. Turner, John M. Sarley, David A. Witt, William A. Olson, Kyle P. Moore
  • Patent number: 11525001
    Abstract: Anti-CD8 antibodies, radiolabeled anti-CD8 antibodies, fluorescently labeled anti-CD8 antibodies and their use in imaging are provided herein. Included are methods of detecting the presence of CD8 proteins in a subject or sample.
    Type: Grant
    Filed: June 26, 2020
    Date of Patent: December 13, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Jason T. Giurleo, Dangshe Ma, William Olson, Richard Tavare, Gavin Thurston
  • Patent number: 11511001
    Abstract: Radiolabeled anti-LAG3 antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of LAG3 proteins in a patient or sample.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: November 29, 2022
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Marcus Kelly, Dangshe Ma, William Olson, Gavin Thurston, Richard Tavare
  • Publication number: 20220356230
    Abstract: The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to a coronavirus spike protein and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections).
    Type: Application
    Filed: March 19, 2021
    Publication date: November 10, 2022
    Inventors: Robert Babb, Alina BAUM, Gang CHEN, Cindy GERSON, Johanna HANSEN, Tammy HUANG, Christos KYRATSOUS, Wen-Yi LEE, Marine MALBEC, Andrew MURPHY, William OLSON, Neil STAHL, George D. YANCOPOULOS